Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of 152.44 million as of February 21, 2025. Its market cap has decreased by -1.94% in one year.

Market Cap

152.44M

Enterprise Value

105.90M

Revenue

28.65M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.20

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 530.53K to 152.44M, an increase of 28,634.56%. That is a compound annual growth rate of 36.20%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	152.44M	15.26%
Dec 31, 2024	132.26M	-27.85%
Dec 29, 2023	183.31M	-21.67%
Dec 30, 2022	234.02M	-20.77%
Dec 31, 2021	295.36M	20.59%
Dec 31, 2020	244.93M	-38.25%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	181.54B
Shell	161.28B
HSBC Holdings	157.51B
Unilever	108.50B
Rio Tinto Group	86.77B
RELX PLC	72.31B
BP p.l.c.	70.06B
British American Tobacco p.l.c.	65.17B

Market Cap Rankings